Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Lung Cancer

  Free Subscription


22.01.2018

1 Am J Respir Crit Care Med
9 Ann Oncol
1 Ann Surg Oncol
1 Ann Thorac Surg
1 BMC Cancer
1 Cancer Chemother Pharmacol
2 Cancer Lett
1 Cancer Res
2 Cancer Sci
2 Clin Cancer Res
2 Clin Lung Cancer
3 Eur J Cancer
2 Eur J Cardiothorac Surg
2 Hum Pathol
1 Int J Cancer
3 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 J Clin Invest
2 J Clin Oncol
1 J Natl Cancer Inst
2 J Thorac Cardiovasc Surg
1 J Thorac Oncol
1 Oncogene
5 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. AJONA D, Zandueta C, Corrales L, Moreno H, et al
    Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.
    Am J Respir Crit Care Med. 2018 Jan 12. doi: 10.1164/rccm.201703-0660.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. HAYASHI H, Mitsudomi T
    S-1 as an option for second-line treatment of NSCLC. Is the 'East Side Story' applicable in the West?
    Ann Oncol. 2017;28:2627-2629.
    PubMed     Text format    

  3. BI N, Liang J, Wang L
    Response to 'Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest'.
    Ann Oncol. 2017;28:3101-3103.
    PubMed     Text format    

  4. MANAPOV F, Eze C
    Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest.
    Ann Oncol. 2017;28:2319-2320.
    PubMed     Text format    

  5. BOLAND JM, Mansfield AS, Roden AC
    Pulmonary sarcomatoid carcinoma-a new hope.
    Ann Oncol. 2017;28:1417-1418.
    PubMed     Text format    

  6. DURUISSEAUX M, Mc Leer-Florin A, Moro-Sibilot D, Cadranel J, et al
    Are ALK rearrangement variants promising predictive biomarker of ALK tyrosine kinase inhibitors efficacy?
    Ann Oncol. 2017;28:1401.
    PubMed     Text format    

  7. LAVOLE A, Guihot A, Veyri M, Lambotte O, et al
    PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?
    Ann Oncol. 2018 Jan 15. pii: 4810471. doi: 10.1093.
    PubMed     Text format    

  8. LI YS, Jiang BY, Yang JJ, Zhang XC, et al
    Unique Genetic Profiles from Cerebrospinal Fluid Cell-free DNA in Leptomeningeal Metastases of EGFR-mutant Non-Small Cell Lung Cancer: A New Medium of Liquid Biopsy.
    Ann Oncol. 2018 Jan 15. pii: 4810473. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. GUIBERT N, Hu Y, Feeney N, Kuang Y, et al
    Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.
    Ann Oncol. 2018 Jan 9. pii: 4794870. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. ADAM J, Le Stang N, Rouquette I, Cazes A, et al
    Multicenter French harmonization study for PD-L1 IHC testing in non-small cell lung cancer.
    Ann Oncol. 2018 Jan 16. pii: 4812668. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  11. TAKAMORI S, Toyokawa G, Okamoto T, Shimokawa M, et al
    Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Jan 11. pii: 10.1245/s10434-017-6328.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  12. HANDA Y, Tsutani Y, Ikeda T, Hanaki H, et al
    Reassessment of Right Middle Lobe Lung Cancer: Comparison of Segments 4 and 5 Tumors.
    Ann Thorac Surg. 2018 Jan 9. pii: S0003-4975(18)30009.
    PubMed     Text format     Abstract available


    BMC Cancer

  13. MOKHLES S, Nuyttens JJME, de Mol M, Aerts JGJV, et al
    Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making.
    BMC Cancer. 2018;18:79.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  14. WANG S, Gao A, Liu J, Sun Y, et al
    First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice?
    Cancer Chemother Pharmacol. 2018 Jan 11. pii: 10.1007/s00280-017-3516.
    PubMed     Text format     Abstract available


    Cancer Lett

  15. LI C, Wan L, Liu Z, Xu G, et al
    Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Cancer Lett. 2018 Jan 12. pii: S0304-3835(18)30058.
    PubMed     Text format     Abstract available

  16. WU D, Zhao B, Qi X, Peng F, et al
    Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
    Cancer Lett. 2018 Jan 10. pii: S0304-3835(18)30052.
    PubMed     Text format     Abstract available


    Cancer Res

  17. DOPESO H, Jiao HK, Cuesta AM, Henze AT, et al
    PHD3 controls lung cancer metastasis and resistance to EGFR inhibitors through TGFalpha.
    Cancer Res. 2018 Jan 16. pii: 0008-5472.CAN-17-1346.
    PubMed     Text format     Abstract available


    Cancer Sci

  18. KATAYAMA R
    Drug resistance in anaplastic lymphoma kinase-rearranged lung cancer.
    Cancer Sci. 2018 Jan 16. doi: 10.1111/cas.13504.
    PubMed     Text format     Abstract available

  19. CHARVAT H, Sasazuki S, Shimazu T, Budhathoki S, et al
    Development of a risk prediction model for lung cancer: the Japan Public Health Center-based Prospective Study.
    Cancer Sci. 2018 Jan 18. doi: 10.1111/cas.13509.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  20. KITAJIMA S, Barbie DA
    RASA1/NF1 mutant lung cancer: Racing to the clinic?
    Clin Cancer Res. 2018 Jan 17. pii: 1078-0432.CCR-17-3597.
    PubMed     Text format     Abstract available

  21. GOLDBERG SB, Narayan A, Kole AJ, Decker RH, et al
    Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA.
    Clin Cancer Res. 2018 Jan 12. pii: 1078-0432.CCR-17-1341.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  22. PARK W, Kwon D, Saravia D, Desai A, et al
    Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30346.
    PubMed     Text format     Abstract available

  23. QIU T, Li W, Zhang T, Xing P, et al
    Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Dec 21. pii: S1525-7304(17)30345.
    PubMed     Text format     Abstract available


    Eur J Cancer

  24. PRADERE P, Michot JM, Champiat S, Danlos FX, et al
    Allergic broncho-pulmonary aspergillosis following treatment with an anti-programmed cell death protein 1 monoclonal antibody therapy.
    Eur J Cancer. 2017;75:308-309.
    PubMed     Text format    

  25. MICHOT JM, Vargaftig J, Leduc C, Quere G, et al
    Immune-related bone marrow failure following anti-PD1 therapy.
    Eur J Cancer. 2017;80:1-4.
    PubMed     Text format    

  26. DEVIC P, Amini-Adle M, Camdessanche JP, Dalle S, et al
    Demyelinating polyradiculoneuropathy under combined BRAF/MEK inhibitors.
    Eur J Cancer. 2017;78:103-104.
    PubMed     Text format    


    Eur J Cardiothorac Surg

  27. GUNN J, Valo J, Sipila J, Rautava P, et al
    Trends and results of lung cancer surgery in Finland between 2004 and 2014.
    Eur J Cardiothorac Surg. 2018 Jan 8. pii: 4793386. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. ARMANI G, Madeddu D, Mazzaschi G, Bocchialini G, et al
    Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Jan 15. pii: 4810371. doi: 10.1093.
    PubMed     Text format     Abstract available


    Hum Pathol

  29. YVOREL V, Forest F, Karpathiou G, Peoc'h M, et al
    BRAF mutations in sarcomatoid and large cell carcinoma of the lung-reply.
    Hum Pathol. 2017;63:220-221.
    PubMed     Text format    

  30. MENGOLI MC, Bettelli S, Gasparri P, Bertolini F, et al
    BRAF mutations in sarcomatoid and large cell carcinoma of the lung.
    Hum Pathol. 2017;63:218-220.
    PubMed     Text format    


    Int J Cancer

  31. SETTE G, Salvati V, Giordani I, Pillozzi E, et al
    Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
    Int J Cancer. 2018 Jan 17. doi: 10.1002/ijc.31260.
    PubMed     Text format     Abstract available


    Int J Oncol

  32. MAJ E, Filip-Psurska B, Milczarek M, Psurski M, et al
    Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
    Int J Oncol. 2018;52:337-366.
    PubMed     Text format     Abstract available

  33. FRILLE A, Leithner K, Olschewski A, Olschewski H, et al
    No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Int J Oncol. 2018;52:518-526.
    PubMed     Text format     Abstract available

  34. KIM J, Hong SW, Kim S, Kim D, et al
    Cyclooxygenase-2 expression is induced by celecoxib treatment in lung cancer cells and is transferred to neighbor cells via exosomes.
    Int J Oncol. 2018;52:613-620.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  35. GOMEZ D
    Induction Chemotherapy with Surgery and Post-operative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:214.
    PubMed     Text format    


    J Clin Invest

  36. CHOCKLEY PJ, Chen J, Chen G, Beer DG, et al
    Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer.
    J Clin Invest. 2018 Jan 11. pii: 97611. doi: 10.1172/JCI97611.
    PubMed     Text format     Abstract available


    J Clin Oncol

  37. RIZVI H, Sanchez-Vega F, La K, Chatila W, et al
    Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand (PD-L)-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.
    J Clin Oncol. 2018 Jan 16:JCO2017753384. doi: 10.1200/JCO.2017.75.3384.
    PubMed     Text format     Abstract available

  38. STOKES WA, Bronsert MR, Meguid RA, Blum MG, et al
    Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2018 Jan 18:JCO2017756536. doi: 10.1200/JCO.2017.75.6536.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  39. CHENG TD, Darke AK, Redman MW, Zirpoli GR, et al
    Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).
    J Natl Cancer Inst. 2018 Jan 13. pii: 4807490. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  40. WEKSLER B
    Resection of pleural implants in patients with lung cancer should remain the exception rather than the rule.
    J Thorac Cardiovasc Surg. 2017 Nov 8. pii: S0022-5223(17)32459.
    PubMed     Text format    

  41. NEGRAO MV, Quek K, Zhang J, Sepesi B, et al
    TRACERx: Tracking tumor evolution to impact the course of lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 16. pii: S0022-5223(17)32689.
    PubMed     Text format    


    J Thorac Oncol

  42. MILLER ED, Fisher JL, Haglund KE, Grecula JC, et al
    The addition of chemotherapy to radiation therapy improves survival in elderly patients with stage III non-small cell lung cancer.
    J Thorac Oncol. 2017 Dec 18. pii: S1556-0864(17)33108.
    PubMed     Text format     Abstract available


    Oncogene

  43. WELCKER D, Jain M, Khurshid S, Jokic M, et al
    AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0054.
    PubMed     Text format     Abstract available


    Oncol Rep

  44. TANG Z, Shen Q, Xie H, Zhou Z, et al
    Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and gamma-ray irradiation was elucidated.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6181.
    PubMed     Text format     Abstract available

  45. FU S, Liu C, Huang Q, Fan S, et al
    Estrogen receptor beta1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6186.
    PubMed     Text format     Abstract available

  46. LI B, Ding CM, Li YX, Peng JC, et al
    Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Oncol Rep. 2018 Jan 15. doi: 10.3892/or.2018.6215.
    PubMed     Text format     Abstract available

  47. KANAJI N, Kamitori K, Hossain A, Noguchi C, et al
    Additive antitumour effect of Dallose in combination with cisplatin in non-small cell lung cancer cells.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6192.
    PubMed     Text format     Abstract available

  48. LIU F, Gao S, Yang Y, Zhao X, et al
    Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6188.
    PubMed     Text format     Abstract available


    PLoS One

  49. CHEN WC, Su VY, Yu WK, Chen YW, et al
    Prognostic factors of noninvasive mechanical ventilation in lung cancer patients with acute respiratory failure.
    PLoS One. 2018;13:e0191204.
    PubMed     Text format     Abstract available


  50. Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLoS One. 2018;13:e0191454.
    PubMed     Text format     Abstract available

  51. CHUANG MC, Yang YH, Tsai YH, Hsieh MJ, et al
    Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
    PLoS One. 2018;13:e0191129.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: